Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Exagen Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 62 | 80 | +18 |
| Shares | 9.05M | 10.8M | +1.75M (+19.3%) |
| Value | $99.5M | $65.7M | −$33.8M (−34.0%) |
New holders (26)
Institutions that held Exagen Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (8)
Institutions that held Exagen Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Invesco Ltd. | 675,192 | $7.42M |
| EAM Investors, LLC | 117,558 | $1.29M |
| EHP Funds Inc. | 90,807 | $998.0K |
| Nkcfo LLC | 40,000 | $440.0K |
| Quadrature Capital Ltd | 11,414 | $124.8K |
| Citigroup Inc | 2,044 | $22.5K |
| Allworth Financial LP | 2,000 | $22.0K |
| Federated Hermes, Inc. | 1,247 | $13.7K |